Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 5/20 | 0.55 |
| ▸ | EGFR | P00533 | 4/20 | 0.55 |
| ▸ | PLK4 | O00444 | 3/20 | 0.44 |
| ▸ | IGF1R | P08069 | 2/20 | 0.39 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | CTRC | Q99895 | 1/20 | 0.36 |
| ▸ | PLK1 | P53350 | 2/20 | 0.36 |
| ▸ | RAF1 | P04049 | 4/20 | 0.35 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.35 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.35 |
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.35 |
| ▸ | MAP1LC3B | Q9GZQ8 | 2/20 | 0.34 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.34 |
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5365551 | 0.92 | ERBB2 (0.60) | ERBB2EGFRPLK4IGF1RLRRK2 | |
| SCHEMBL5368253 | 0.90 | ERBB2 (0.67) | ERBB2EGFRPLK4IGF1RLRRK2 | |
| SCHEMBL5362833 | 0.88 | ERBB2 (0.57) | ERBB2EGFRPLK4IGF1RLRRK2 | |
| SCHEMBL5361618 | 0.85 | ERBB2 (0.48) | ERBB2EGFRPLK4IGF1RMAPT | |
| SCHEMBL5358664 | 0.84 | ERBB2 (0.52) | ERBB2EGFRPLK4IGF1RLRRK2 | |
| SCHEMBL7135150 | 0.82 | ERBB2 (0.49) | ERBB2EGFRPLK4IGF1RLRRK2 | |
| SCHEMBL5363945 | 0.81 | ERBB2 (0.58) | ERBB2EGFRIGF1RCTRCMAP1LC3B | |
| SCHEMBL5365913 | 0.80 | LRRK2 (0.54) | ERBB2EGFRPLK4IGF1RLRRK2 | |
| SCHEMBL5366145 | 0.79 | EGFR (0.53) | ERBB2EGFRPLK4IGF1RLRRK2 | |
| SCHEMBL5362117 | 0.79 | ERBB2 (0.52) | ERBB2EGFRPLK4IGF1RMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7202265-B2 | Indolinone combinatorial libraries and related products and methods for the treatment of disease | SUGEN, INC. (US) | 2007-04-10 | — | — | US | disclosed |
| US-20050197382-A1 | Indolinone combinatorial libraries and related products and methods for the treatment of disease | SUGEN, INC. | 2005-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197382-A1 | Indolinone combinatorial libraries and related products and methods for the treatment of disease | FRK, PTK2, DSTYK | ERBB2 19/4885EGFR 286/4885PLK4 42/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.